Back | Next |
home / stock / tgtx / tgtx message board
Subject | By | Source | When |
---|---|---|---|
$TGTX Found an interesting article | makinezmoney | investorshub | 04/16/2023 2:51:42 AM |
$TGTX When is this gonna take off? | tw0122 | investorshub | 04/16/2023 1:43:37 AM |
$TGTX Price trading | tw0122 | investorshub | 04/14/2023 8:54:57 PM |
$TGTX Good news recently, we should start to see this one move | tw0122 | investorshub | 04/14/2023 11:20:07 AM |
MomentumIts now up | tw0122 | investorshub | 04/14/2023 12:13:19 AM |
short data if anyone is interested | tw0122 | investorshub | 04/14/2023 12:02:23 AM |
$TGTX Good news recently, we should start to see this one move | pennyfinder | investorshub | 04/13/2023 5:34:02 PM |
what do you make of this data? | Imarket13 | investorshub | 04/12/2023 7:10:42 PM |
Where did you find such news? | Alan Brown | investorshub | 04/12/2023 2:27:09 PM |
whytestocks: $TGTX News Article - Why Shares of TG Therapeutics Soared on Tuesday | whytestocks | investorshangout | 04/11/2023 6:05:48 PM |
what does this mean? | Imarket13 | investorshub | 04/11/2023 4:56:53 PM |
$TGTX Price now up | Ringrock | investorshub | 04/11/2023 3:02:24 AM |
$TGTX we got news | Imarket13 | investorshub | 04/09/2023 11:31:07 PM |
$TGTX Anyone hear anything lately? Want to see this one go | tw0122 | investorshub | 04/09/2023 8:12:30 AM |
oh yeah news for the day | makinezmoney | investorshub | 04/08/2023 2:15:57 PM |
$TGTX What do you make of this? | tw0122 | investorshub | 04/07/2023 8:33:12 AM |
$TGTX short squeeze all day | airman1 | investorshub | 04/07/2023 7:59:55 AM |
where is the squeeze? | teifhals | investorshub | 04/06/2023 8:40:00 PM |
$TGTX great article | airman1 | investorshub | 04/06/2023 2:47:03 PM |
Price now | shamalamadingdong | investorshub | 04/05/2023 8:21:33 PM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), announced that it has been awarded a national contract with th...
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI ® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at t...
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced that it has been awarded a national contract with the Department of Veterans Affairs (VA) for BRIUMVI® (ublituximab-xiiy) to be the preferred agent listed on the VA National Formulary for Anti-CD20 A...